Evidence map›Paper›PMID 23981039›Full record

ReviewImmunology2014

Oligodendrocyte-microglia cross-talk in the central nervous system.

Laura Peferoen, Markus Kipp, Paul van der Valk, Johannes M van Noort, Sandra Amor

Abstract readReview
In one paragraph

Review in Immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 262 papers.

0numbers the graph read from it
0cells of the map it votes in
262citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

262 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Role of HMGB1 in Neuroinflammation.Molecular neurobiology · 2026
    Review
  5. Article
  6. Article
  7. TREM2 in neurodegeneration and diseases.Molecular psychiatry · 2026
    Review
  8. Article
  9. Article
  10. cGAS inhibition delays TDP-43-driven ALS Pathogenesis.bioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

202 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura PeferoenPathology Department, VU University Medical Centre, Amsterdam, the Netherlands.
Markus Kipp
Paul van der Valk
Johannes M van Noort
Sandra Amor

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Communication between the immune system and the central nervous system (CNS) is exemplified by cross-talk between glia and neurons shown to be essential for maintaining homeostasis. While microglia are actively modulated by neurons in the healthy brain, little is known about the cross-talk between oligodendrocytes and microglia. Oligodendrocytes, the myelin-forming cells in the CNS, are essential for the propagation of action potentials along axons, and additionally serve to support neurons by producing neurotrophic factors. In demyelinating diseases such as multiple sclerosis, oligodendrocytes are thought to be the victims. Here, we review evidence that oligodendrocytes also have strong immune functions, express a wide variety of innate immune receptors, and produce and respond to chemokines and cytokines that modulate immune responses in the CNS. We also review evidence that during stress events in the brain, oligodendrocytes can trigger a cascade of protective and regenerative responses, in addition to responses that elicit progressive neurodegeneration. Knowledge of the cross-talk between microglia and oligodendrocytes may continue to uncover novel pathways of immune regulation in the brain that could be further exploited to control neuroinflammation and degeneration.

Indexed as

Cell CommunicationSignal TransductionAnimalsBrainCytokinesDemyelinating DiseasesExosomesHeat-Shock ProteinsHumansMicrogliaMyelin SheathOligodendrogliaStress, PhysiologicalCytokinesHeat-Shock Proteinsheat-shock proteinsimmune responsemicroglianeurodegenerationoligodendrocytes

Identifiers

PMID23981039
PMCPMC3930369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.